These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25134047)

  • 1. Employment-based reinforcement of adherence to oral naltrexone in unemployed injection drug users: 12-month outcomes.
    Dunn K; DeFulio A; Everly JJ; Donlin WD; Aklin WM; Nuzzo PA; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Psychol Addict Behav; 2015 Jun; 29(2):270-6. PubMed ID: 25134047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.
    Dunn KE; Defulio A; Everly JJ; Donlin WD; Aklin WM; Nuzzo PA; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Exp Clin Psychopharmacol; 2013 Feb; 21(1):74-83. PubMed ID: 23205722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.
    Everly JJ; DeFulio A; Koffarnus MN; Leoutsakos JM; Donlin WD; Aklin WM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Addiction; 2011 Jul; 106(7):1309-18. PubMed ID: 21320227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial.
    DeFulio A; Everly JJ; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Drug Alcohol Depend; 2012 Jan; 120(1-3):48-54. PubMed ID: 21782353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users.
    Holtyn AF; Koffarnus MN; DeFulio A; Sigurdsson SO; Strain EC; Schwartz RP; Silverman K
    J Appl Behav Anal; 2014; 47(4):681-93. PubMed ID: 25292399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
    Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patients.
    Dunn KE; Fingerhood M; Wong CJ; Svikis DS; Nuzzo P; Silverman K
    Exp Clin Psychopharmacol; 2014 Feb; 22(1):75-85. PubMed ID: 24490712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.
    Holtyn AF; Koffarnus MN; DeFulio A; Sigurdsson SO; Strain EC; Schwartz RP; Leoutsakos JM; Silverman K
    Prev Med; 2014 Nov; 68():62-70. PubMed ID: 24607365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
    Jarvis BP; Holtyn AF; Berry MS; Subramaniam S; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    J Subst Abuse Treat; 2018 Feb; 85():38-44. PubMed ID: 28449955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: post-intervention outcomes.
    DeFulio A; Silverman K
    Addiction; 2011 May; 106(5):960-7. PubMed ID: 21226886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.
    Ling W; Hillhouse MP; Saxon AJ; Mooney LJ; Thomas CM; Ang A; Matthews AG; Hasson A; Annon J; Sparenborg S; Liu DS; McCormack J; Church S; Swafford W; Drexler K; Schuman C; Ross S; Wiest K; Korthuis PT; Lawson W; Brigham GS; Knox PC; Dawes M; Rotrosen J
    Addiction; 2016 Aug; 111(8):1416-27. PubMed ID: 26948856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of reinforcement to address the chronic nature of drug addiction.
    Silverman K; DeFulio A; Sigurdsson SO
    Prev Med; 2012 Nov; 55 Suppl(Suppl):S46-53. PubMed ID: 22668883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abstinence-contingent wage supplements to promote drug abstinence and employment: Post-intervention outcomes.
    Novak MD; Holtyn AF; Toegel F; Leoutsakos JM; Silverman K
    Drug Alcohol Depend; 2022 Mar; 232():109322. PubMed ID: 35077956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial.
    DeFulio A; Donlin WD; Wong CJ; Silverman K
    Addiction; 2009 Sep; 104(9):1530-8. PubMed ID: 19686522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry.
    Saxon AJ; Akerman SC; Liu CC; Sullivan MA; Silverman BL; Vocci FJ
    Addiction; 2018 Aug; 113(8):1477-1487. PubMed ID: 29493836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
    Adi Y; Juarez-Garcia A; Wang D; Jowett S; Frew E; Day E; Bayliss S; Roberts T; Burls A
    Health Technol Assess; 2007 Feb; 11(6):iii-iv, 1-85. PubMed ID: 17280624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
    Hermes G; Hyman SM; Fogelman N; Kosten TR; Sinha R
    Am J Addict; 2019 Nov; 28(6):480-488. PubMed ID: 31448846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
    Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Boney TY; Hoskinson RA; Wilson D; McDonald R; Rotrosen J; Gourevitch MN; Gordon M; Fishman M; Chen DT; Bonnie RJ; Cornish JW; Murphy SM; O'Brien CP
    N Engl J Med; 2016 Mar; 374(13):1232-42. PubMed ID: 27028913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circumstances of death of opioid users being treated with naltrexone.
    Darke S; Farrell M; Duflou J; Larance B; Lappin J
    Addiction; 2019 Nov; 114(11):2000-2007. PubMed ID: 31278812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.
    Aklin WM; Severtson SG; Umbricht A; Fingerhood M; Bigelow GE; Lejuez CW; Silverman K
    J Clin Psychiatry; 2012 Aug; 73(8):e1056-61. PubMed ID: 22967782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.